Bioactive peptides: Improving the future of diabetes therapy

Basit Öğe Kaydı
dc.authorscopusid57220178117
dc.authorscopusid57188963997
dc.authorscopusid57191349507
dc.authorscopusid6602258835
dc.contributor.authorTok K.
dc.contributor.authorMoulahoum H.
dc.contributor.authorKocadag Kocazorbaz E.
dc.contributor.authorZihnioglu F.
dc.date.accessioned2023-01-12T20:22:36Z
dc.date.available2023-01-12T20:22:36Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractDiabetes mellitus is a complex disease with significant consequences on health, societies, and the economy alike. The tandem presence of some diseases with diabetes highly underlines the urgency for efficient solutions. Many compounds are being used to control/balance glucose and insulin levels. Natural product-based proteins and peptides have been a part of the traditional medication. They possess both nutritional activities and health benefits. In addition to their economic and easy production, their advantage relies on their accessibility, biocompatibility, and diminutive adverse effects. This chapter will provide a comprehensive understanding of diabetes (including its complications) and the importance of bioactive peptides in antidiabetic therapy. Hence, this chapter will present the latest advances in multifunctional bioactive peptide discovery. We will also demonstrate the enormous unexploited potential of bioactive peptides that could be valuable in designing future diabetes therapeutics. © 2022 Elsevier B.V.en_US
dc.description.sponsorshipThe authors are thankful for the creative help provided by Kadir Kaan Tok. Dr. Faezeh Ghorbanizamani is also thanked for the meaningful discussions and her input during the writing of this manuscript.en_US
dc.identifier.doi10.1016/B978-0-323-91250-1.00003-3
dc.identifier.endpage74en_US
dc.identifier.issn15725995
dc.identifier.issn1572-5995en_US
dc.identifier.scopus2-s2.0-85139251169en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage41en_US
dc.identifier.urihttps://doi.org/10.1016/B978-0-323-91250-1.00003-3
dc.identifier.urihttps://hdl.handle.net/11454/79520
dc.identifier.volume75en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofStudies in Natural Products Chemistryen_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectACEen_US
dc.subjectBioactive peptidesen_US
dc.subjectDiabetesen_US
dc.subjectDPP4en_US
dc.subjectMultifunctional peptidesen_US
dc.subject?-Amylase and ?-glucosidaseen_US
dc.titleBioactive peptides: Improving the future of diabetes therapyen_US
dc.typeBook Chapteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu